Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment.
Nat Genet. 1999 Jun;22(2):168-70. doi: 10.1038/9680.
Nat Genet. 1999.
PMID: 10369259
Clinical Trial.
Pharmacokinetics of a novel 5-lipoxygenase inhibitor (ABT-761) in pediatric patients with asthma.
Wong SL, Kearns GL, Kemp JP, Drajesk J, Chang M, Locke CS, Dube LM, Awni WM.
Wong SL, et al. Among authors: drajesk j.
Eur J Clin Pharmacol. 1998 Nov-Dec;54(9-10):715-9. doi: 10.1007/s002280050540.
Eur J Clin Pharmacol. 1998.
PMID: 9923573
Clinical Trial.
Item in Clipboard
Clinical observation of liver chemistry abnormalities in asthmatics.
Katz DA, Isaacson JD, Han L, Drajesk JF, Comer GM, Heath-Chiozzi ME.
Katz DA, et al. Among authors: drajesk jf.
Curr Drug Saf. 2009 Sep;4(3):173-80. doi: 10.2174/157488609789006930. Epub 2009 Sep 1.
Curr Drug Saf. 2009.
PMID: 19534645
Item in Clipboard
Pharmacokinetics of zileuton and its metabolites in patients with renal impairment.
Awni WM, Wong S, Chu SY, Patterson K, Hansen R, Machinist JM, Drajesk J, Keane WF, Halstenson CE.
Awni WM, et al. Among authors: drajesk j.
J Clin Pharmacol. 1997 May;37(5):395-404. doi: 10.1002/j.1552-4604.1997.tb04317.x.
J Clin Pharmacol. 1997.
PMID: 9156372
Clinical Trial.
Item in Clipboard
Pharmacokinetics and pharmacodynamics of single and multiple oral doses of a novel 5-lipoxygenase inhibitor (ABT-761) in healthy volunteers.
Wong SL, Drajesk J, Chang M, Lanni C, Witt G, Hansen R, Awni WM.
Wong SL, et al. Among authors: drajesk j.
Clin Pharmacol Ther. 1998 Mar;63(3):324-31. doi: 10.1016/S0009-9236(98)90164-3.
Clin Pharmacol Ther. 1998.
PMID: 9542476
Clinical Trial.
Item in Clipboard
Dose-proportional pharmacokinetics of a new 5-lipoxygenase inhibitor, ABT-761, in healthy volunteers.
Wong SL, Drajesk J, Chang MS, Witt G, Awni WM.
Wong SL, et al. Among authors: drajesk j.
Biopharm Drug Dispos. 1998 Apr;19(3):159-62. doi: 10.1002/(sici)1099-081x(199804)19:3<159::aid-bdd80>3.0.co;2-o.
Biopharm Drug Dispos. 1998.
PMID: 9569998
Clinical Trial.
Item in Clipboard
The effect of ABT-761, a novel 5-lipoxygenase inhibitor, on exercise- and adenosine-induced bronchoconstriction in asthmatic subjects.
Van Schoor J, Joos GF, Kips JC, Drajesk JF, Carpentier PJ, Pauwels RA.
Van Schoor J, et al. Among authors: drajesk jf.
Am J Respir Crit Care Med. 1997 Mar;155(3):875-80. doi: 10.1164/ajrccm.155.3.9117020.
Am J Respir Crit Care Med. 1997.
PMID: 9117020
Clinical Trial.
Item in Clipboard
Phase I trial of H65-RTA immunoconjugate in patients with cutaneous T-cell lymphoma.
LeMaistre CF, Rosen S, Frankel A, Kornfeld S, Saria E, Meneghetti C, Drajesk J, Fishwild D, Scannon P, Byers V.
LeMaistre CF, et al. Among authors: drajesk j.
Blood. 1991 Sep 1;78(5):1173-82.
Blood. 1991.
PMID: 1878584
Free article.
Clinical Trial.
Item in Clipboard
Cite
Cite